Abstract

 Given the novel nature of COVID-19, there is currently no proven treatment beyond supportive care, but robust public health interventions have been introduced internationally to curtail disease transmission, minimize the burden on healthcare systems and protect vulnerable populations, including elderly people and those with existing medical comorbidities. Though coronavirus primarily affects respiratory system, cardiovascular complications such as myocarditis, acute coronary syndrome, exacerbations of heart failure and arrhythmia are not unknown. The general management of acute coronary syndromes (ACS) are well defined in AHA/ACC and European guidelines, but guidelines in the management of ACS in COVID-19 suspected or positive patients are scarce. At the same time, there is an urgent need to manage cardiovascular emergencies with appropriate standards of care and dedicated preventive measures. We present here the protocol dedicated to ACS patients adopted in our centre since March 13, 2020 and our initial experience in the management of ACS patients during the first 3 months of its implementation.

Keywords: COVID-19; Acute Coronary Syndromes (ACS)

References

1. World Health Organization. “Pneumonia of unknown cause - China” (2020).
2. Ete T., et al. "Disease, Drugs and Dilemma: A Review of Cardiovascular Implications of Novel COVID-19”. Clinical Infection and Immunity2 (2020): 25-30.
3. Driggin E., et al. "Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic”. Journal of the American College of Cardiology 18 (2020): 2352-2371.
4. Wang D., et al. "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China”. Journal of the American Medical Association11 (2020): 1061-1069.
5. Zhou F., et al. "Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study”. Lancet 10229 (2020): 1054-1062.
6. Li B., et al. "Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China”. Clinical Research in Cardiology 5 (2020): 531-538.
7. Chen T., et al. "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study”. British Medical Journal 368 (2020): m1091.
8. De Filippo O., et al. "Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy”. New England Journal of Medicine 1 (2020): 88-89.
9. Wang D., et al. "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. Journal of the American Medical Association11 (2020): 1061-1069.
10. Duane S Pinto., et al. “Coronavirus disease 2019 (COVID-19): Myocardial infarction and other coronary artery disease issues”. UpToDate (2020).
11. Zhi-Cheng Jing., et al. “COVID-19 & AMI Committee of Peking Union Medical College Hospital Recommendations from the Peking Union Medical College Hospital for the management of Acute Myocardial Infarction during the COVID-19 outbreak”. European Heart Journal 31 (2020): ehaa258.
12. Guha S., et al. “Managing ACS during COVID-19 infection: Do not follow the traditional route”. Indian Heart Journal 2 (2020): 128-130.
13. F Zhou., et al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study”. Lancet10229 (2020): 1054-1062.
14. Zhou X., et al. “Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19: Implications from Clinical Features to Pathologic Findings”. Circulation22 (2020): 1736-1738.
15. Tabaza L., et al. “Robotic-assisted percutaneous coronary intervention in a COVID-19 patient”. Catheterization and Cardiovascular Interventions (2020).

Citation

Citation: Animesh Mishra., et al. “Coronary Intervention in a Tertiary Care Centre in North Eastern India during Covid-19 Pandemic- Protocol and Management". Acta Scientific Clinical Case Reports 1.7 (2020): 14-18.

Copyright

Copyright: © 2020 Animesh Mishra., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.